Sponsor Pipeline

CVRx, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Disease Areas
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-31 NCT04502316
Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE…		 critical Trial terminated
2026-07-31 NCT04502316
Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE…		 critical Trial terminated: Participant follow-up through 12 months post-Barostim Implant sufficient for data collection and analysis purposes.
2026-07-31 NCT04502316
Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE…		 Enrollment reduced: 5000 -> 435 participants
2026-07-31 NCT04502316
Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE…		 date change Primary completion moved earlier: 2028-06 -> 2026-05-14
2026-07-31 NCT04502316
Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE…		 date change Completion moved earlier: 2028-06 -> 2026-06-30
Active Trials by Phase
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT01471834 Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of… High Blood Pressure Active, Not Recruiting
NCT07232030 Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure Heart Failure Enrolling by Invitation
Disease Areas
Hypertension (1) Heart Failure (1)
Get alerts when CVRx, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free